Papuan taipan venom toxins

Other major Papuan taipan venom toxins refers to the suite of highly potent bioactive proteins found in the venom of the Papuan taipan (Oxyuranus scutellatus canni), excluding the primary presynaptic neurotoxin, taipoxin (or cannitoxin). This group is dominated by the prothrombin activator complex, Oscutarin C, which is a Factor Xa-like serine protease that triggers rapid venom-induced consumption coagulopathy (VICC) by converting prothrombin into thrombin. Additionally, it includes postsynaptic three-finger toxins (3FTxs) such as alpha-oxytoxin 1, which competitively inhibit nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. Other significant components include taicatoxin, which modulates voltage-gated calcium channels, and various natriuretic peptides and Kunitz-type protease inhibitors that disrupt cardiovascular and hemostatic stability. These toxins are the primary therapeutic targets for neutralization by specific and polyvalent antivenoms, which utilize polyclonal antibodies to prevent lethal systemic effects. Understanding the synergy between these toxins is critical for the development of next-generation antivenoms and small-molecule inhibitors like varespladib.

Other names

Other major Papuan taipan venom toxinsOxyuranus scutellatus canni toxinsPapuan taipan venom componentsOscutarin CAlpha-oxytoxin 1Taicatoxin

Antivenoms provide passive immunity by delivering polyclonal antibodies (IgG or F(ab')2 fragments) that bind to specific epitopes on the toxins, neutralizing their enzymatic activity or preventing their binding to physiological targets such as prothrombin or acetylcholine receptors. Varespladib is a small-molecule inhibitor that specifically targets the active site of phospholipase A2 (PLA2) enzymes, which are components of several taipan toxins.